{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:00Z","timestamp":1786988040328,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016916","name":"Royal Marsden Cancer Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016610","name":"Andrew McDonough B+ Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002002","name":"Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017012","name":"Children\u2019s Oncology Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018762","name":"Seattle Children's Foundation","doi-asserted-by":"publisher","award":["CWS-91"],"award-info":[{"award-number":["CWS-91"]}],"id":[{"id":"10.13039\/100018762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006282","name":"Koning Boudewijnstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003287","name":"Rally Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejca.2025.115793","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:28:58Z","timestamp":1757770138000},"page":"115793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9932-1944","authenticated-orcid":false,"given":"Federico","family":"Mercolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9551-2399","authenticated-orcid":false,"given":"Monika","family":"Sparber-Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.M.","family":"Merks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Koscielniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-6249","authenticated-orcid":false,"given":"Christine M.","family":"Heske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-7997","authenticated-orcid":false,"given":"Julia","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4411-0332","authenticated-orcid":false,"given":"Beatrice","family":"Coppadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Harrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6851-7653","authenticated-orcid":false,"given":"Dana L.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9280-1451","authenticated-orcid":false,"given":"Guido","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-4937","authenticated-orcid":false,"given":"Roshni","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-106X","authenticated-orcid":false,"given":"Rajkumar","family":"Venkatramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4462-5523","authenticated-orcid":false,"given":"Gianni","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejca.2025.115793_bib1","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.22.02093","article-title":"Nonmetastatic rhabdomyosarcoma in children and adolescents: overall results of the european pediatric soft tissue sarcoma study group RMS2005 study","volume":"41","author":"Bisogno","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2025.115793_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26645","article-title":"Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: a report from the children's oncology group","volume":"64","author":"Rudzinski","year":"2017","journal-title":"Pedia Blood Cancer"},{"issue":"32","key":"10.1016\/j.ejca.2025.115793_bib3","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.21.02981","article-title":"Metastatic rhabdomyosarcoma: results of the european paediatric soft tissue sarcoma study group MTS 2008 study and pooled analysis with the concurrent BERNIE study","volume":"40","author":"Schoot","year":"2022","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ejca.2025.115793_bib4","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1200\/JCO.2007.14.7207","article-title":"Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and european cooperative groups","volume":"26","author":"Oberlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2025.115793_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30293","article-title":"Rhabdomyosarcoma with isolated lung metastases: a report from the soft tissue sarcoma committee of the children's oncology group","volume":"70","author":"Vasquez","year":"2023","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.115793_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpedsurg.2004.09.045","article-title":"Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV","volume":"40","author":"Rodeberg","year":"2005","journal-title":"J Pedia Surg"},{"issue":"10","key":"10.1016\/j.ejca.2025.115793_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26510","article-title":"The prognostic value of early radiographic response in children and adolescents with embryonal rhabdomyosarcoma stage IV, metastases confined to the lungs: a report from the cooperative weichteilsarkom studiengruppe (CWS)","volume":"64","author":"Sparber-Sauer","year":"2017","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.ejca.2025.115793_bib8","article-title":"Outcomes in lung-only metastatic rhabdomyosarcoma: ana anlisys of data from the european pediatric soft tissue sarcoma study group MTS 2008 study","author":"Chisholm","year":"2023","journal-title":"Eur J Cancer Pediatr Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.115793_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30143","article-title":"Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: a european pediatric soft tissue sarcoma study group (EpSSG) report","volume":"70","author":"Mercolini","year":"2023","journal-title":"Pedia Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2025.115793_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28701","article-title":"Introducing INSTRuCT: an international effort to promote cooperation and data sharing","volume":"70","author":"Hawkins","year":"2023","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.115793_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pbc.24118","article-title":"Rhabdomyosarcoma: review of the children's oncology group (COG) Soft-Tissue sarcoma committee experience and rationale for current COG studies","volume":"59","author":"Malempati","year":"2012","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.ejca.2025.115793_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2021.07.006","article-title":"Role of 18F-FDG-PET\/CT in the staging of metastatic rhabdomyosarcoma: a report from the european paediatric soft tissue sarcoma study group","volume":"155","author":"Mercolini","year":"2021","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2025.115793_bib13","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3390\/cancers15072050","article-title":"Pediatric patients with stage IV rhabdomyosarcoma significantly benefit from Long-Term maintenance therapy: results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials","volume":"15","author":"Tramsen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ejca.2025.115793_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/cncr.31770","article-title":"The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: a report from the children's oncology group","volume":"125","author":"Malempati","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2025.115793_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/JCO.2015.63.4048","article-title":"Intensive multiagent therapy, including Dose-Compressed cycles of Ifosfamide\/Etoposide and vincristine \/ doxorubicin \/ cyclophosphamide, irinotecan, and radiation, in patients with High-Risk rhabdomyosarcoma: a report from the children's oncology group","volume":"34","author":"Weigel","year":"2016","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.ejca.2025.115793_bib16","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1200\/JCO.2009.22.3768","article-title":"Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803","volume":"27","author":"Arndt","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2025.115793_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/pbc.21494","article-title":"Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial","volume":"50","author":"Klingebiel","year":"2008","journal-title":"Pedia Blood Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2025.115793_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/cancers14040899","article-title":"Long-Term clinical outcome and prognostic factors of children and adolescents with localized rhabdomyosarcoma treated on the CWS-2002P protocol","volume":"14","author":"Koscielniak","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.ejca.2025.115793_bib19","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1200\/JCO.2007.15.0466","article-title":"Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults","volume":"27","author":"Dantonello","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2025.115793_bib20","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3390\/cancers15072050","article-title":"Pediatric patients with stage IV rhabdomyosarcoma significantly benefit from Long-Term maintenance therapy: results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials","volume":"15","author":"Tramsen","year":"2023","journal-title":"Cancers"},{"issue":"20","key":"10.1016\/j.ejca.2025.115793_bib21","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2011.40.3287","volume":"30","author":"Oberlin","year":"2012","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.ejca.2025.115793_bib22","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.ejca.2009.08.019","article-title":"Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma","volume":"45","author":"Bisogno","year":"2009","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2025.115793_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1470-2045(24)00255-9","article-title":"Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the children's oncology group","volume":"25","author":"Gupta","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115793_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102957","article-title":"Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial","volume":"78","author":"Koscielniak","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.ejca.2025.115793_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70215","article-title":"Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the cooperative weichteilsarkom studiengruppe CWS","volume":"14","author":"Koscielniak","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2025.115793_bib26","doi-asserted-by":"crossref","unstructured":"Chisholm J.C., Merks J.H.M., Casanova M., et al. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study). Eur J Cancer. 2027;83:177-184.","DOI":"10.1016\/j.ejca.2017.06.015"},{"issue":"1","key":"10.1016\/j.ejca.2025.115793_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30707","article-title":"Significance of fusion status, oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: data of the european soft tissue sarcoma registry SoTiSaR","volume":"71","author":"Heinz","year":"2024","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.ejca.2025.115793_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.878367","article-title":"No improvement of survival for alveolar rhabdomyosarcoma patients after HLA-matched versus \u2013mismatched allogenic hematopoietic stem cell transplantation compared to standard of care therapy","volume":"12","author":"Schober","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.115793_bib29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a european society for radiotherapy and oncology and european organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2025.115793_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28219","article-title":"Pediatric rhabdomyosarcoma with bone marrow metastasis","volume":"67","author":"Bailey","year":"2020","journal-title":"Pedia Blood Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2025.115793_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30701","article-title":"Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on children's oncology group studies","volume":"70","author":"Schloemer","year":"2023","journal-title":"Pedia Blood Cancer"},{"issue":"14","key":"10.1016\/j.ejca.2025.115793_bib32","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1002\/cam4.2504","article-title":"Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the children's oncology group","volume":"8","author":"Hibbitts","year":"2019","journal-title":"Cancer Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925005799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925005799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:49:00Z","timestamp":1773110940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925005799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"alternative-id":["S0959804925005799"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115793","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115793"}}